Anshul Jain, Ph.D.

Anshul is a trusted strategic partner to leaders navigating the high-stakes decisions of drug development and commercialization. Drawing on experience across the full arc from molecule to market, he has guided clients through foundational launches, geographic expansions, portfolio re-entries, pipeline transformations, M&A targeting, and organizational design.

With over a decade of strategic advisory experience and a multidisciplinary research background, Anshul has directly led 40+ engagements across the oncology, immunology, neurology, cardiovascular, infectious disease, and rare disease spaces.

Anshul collaborates with R&D, Medical Affairs, and Commercial teams, and is a recognized builder of competitive intelligence frameworks, scenario gaming methodologies, and launch/GTM strategies. He is also an unabashed advocate of fully integrated, cross-functional product strategy for any molecular asset with the potential to save and improve lives.

Anshul holds a Ph.D. from Boston University and a B.A. from Duke University. In his free time, he is passionate about travel, cartography, food & wine, art & architecture, and music, and is a regular blood donor.